Building an RFP for a Saudi Digital Patient Support Program

Building an RFP for a Saudi Digital Patient Support Program

A well-constructed Request for Proposals is the most effective instrument a pharmaceutical procurement team has to compare PSP vendors fairly, surface capability gaps before contract signature, and create a defensible record of how the selection decision was made. In Saudi Arabia's emerging digital PSP market, where vendor claims frequently outpace verified capabilities, a rigorous RFP process protects the sponsor organization from costly program redesigns after go-live.

This article provides the structure for a Saudi digital PSP RFP, a question bank organized by role, and guidance on scoring methodology and pilot terms.

---

Key Takeaways

• An RFP for a Saudi digital PSP should cover six functional domains: technology platform, pharmacovigilance, data privacy and hosting, Arabic UX and patient experience, program governance, and commercial terms.
• Questions should be allocated by committee role — not every member of the evaluation committee needs to review every question. Allocate questions to the stakeholders best positioned to evaluate the answers.
• Pilot terms should be defined in the RFP, not negotiated post-award — the conditions under which a pilot can convert to a full program, and the conditions under which it cannot, should be agreed before the pilot begins.
• Keywords are unvalidated editorial hypotheses (H); no search volume claims are made.

---

Why RFP Structure Matters More Than RFP Length

Many Saudi PSP procurement processes begin with a conversation at a conference and end with a contract signed on the basis of a demo and a reference call. This approach works well when the market has established, well-understood vendors and standardized product categories. The digital PSP platform market in Saudi Arabia is neither.

A structured RFP accomplishes several things that an unstructured evaluation cannot:

It forces vendors to respond to your program requirements, not their product defaults. A vendor demo shows you what the platform does well; an RFP response shows you whether it can do what you specifically need.

It creates a written record of vendor claims. When a vendor states in writing that their platform supports in-Kingdom data hosting, SFDA-compatible AE reporting, and full Arabic RTL across all workflows, that claim becomes part of the contract foundation. Verbal claims made in a demo do not.

It surfaces capability gaps before they become program failures. Vendors who struggle to answer detailed questions about PDPL compliance architecture or AE reconciliation workflow are signaling real gaps — not just communication failures.

It enables parallel evaluation across multiple evaluators. A procurement committee that receives identical questions, answered identically by all vendors, can divide evaluation responsibility by domain expertise and aggregate scores consistently.

---

RFP Structure: Six Sections

Section 1: Company and Market Background

This section establishes vendor credentials in the Saudi and GCC healthcare market.

Questions for procurement and medical affairs:

• In which Saudi healthcare markets is your platform currently live? Provide references.
• Do you have a legal entity or operational presence in the Kingdom?
• What is the current patient enrollment across active Saudi PSP programs on your platform?
• Provide three references from Saudi pharma sponsors with programs currently operating on your platform.

Section 2: Technology Platform

This section evaluates the platform's core capabilities and configurability.

Questions for IT and technology leads:

• Describe your platform's architecture. Is it multi-tenant or single-tenant? Cloud-native or legacy?
• What is your published uptime SLA, and what are your remedies for SLA breaches?
• How are program-specific configurations implemented? Can workflow changes be made without development work?
• What APIs are available for HIS/EMR integration? Provide technical API documentation.
• Describe your release cycle and how customers are notified of platform changes.
• What testing and validation protocols are in place before platform updates are released?

Questions for clinical and program leads:

• Demonstrate a Saudi-relevant therapy workflow end-to-end in your platform sandbox.
• Can the platform support multi-step conditional enrollment based on HCP-verified patient eligibility?
• How does the platform handle patients who disengage and re-engage after a gap?

Section 3: Pharmacovigilance and Safety

This section is mandatory for the medical affairs and pharmacovigilance committee members, and should be evaluated with PV expertise.

Questions for pharmacovigilance and medical affairs:

• How does your platform classify patient-reported health changes — specifically, does it systematically prompt identification of potential adverse events at every patient interaction?
• Describe the minimum valid dataset your platform captures for a potential adverse event report.
• What is the typical workflow from a patient-reported symptom to transmission to the sponsor's safety contact?
• Provide a sample SDEA template used in your Saudi PSP programs.
• How does your platform generate a reconciliation report for the sponsor's global safety database? Demonstrate the format.
• Describe your approach to AE capture in multilingual (Arabic/English) patient interactions.
• What training do your coordinators receive on adverse event identification, and how are training records maintained? [HOLD — expert review: specific responses require PV professional evaluation]

Section 4: Data Privacy and Hosting

Questions for legal, privacy, and IT:

• Where is patient health data hosted? Specify data center location(s) and certifications.
• Is in-Kingdom data hosting available as a standard option, or as a custom arrangement?
• Provide your standard Data Processing Agreement template.
• How does your platform classify health data under Saudi PDPL? Specifically, how is consent captured, versioned, and stored?
• Describe your approach to data subject rights requests under PDPL.
• What is your breach notification process and timeline?
• Do you have ISO 27001 or equivalent certification? Provide evidence. [VERIFY WITH BRAND — specific hosting certifications require technical verification]

Section 5: Arabic UX and Patient Experience

Questions for patient experience, marketing, and medical affairs:

• Demonstrate your patient-facing application in Arabic on a mobile device — including enrollment, medication reminder, AE prompt, and self-report flow.
• Is the Arabic version of your platform developed in parallel with the English version, or derived from English with translation?
• How are patient-facing communications (SMS, push notifications, in-app messages) generated in Arabic? Are they templated, dynamically generated, or both?
• How do you test Arabic UX with Saudi patient populations?
• Describe how your platform supports family members (caregivers) registered alongside the patient.

Section 6: Commercial Terms and Implementation

Questions for procurement and finance:

• Provide fully itemized pricing for the following scenarios: [insert enrollment estimate at Year 1, active patients at Year 2, and expected monthly interaction volume].
• What is included in your standard implementation fee? What is excluded?
• What is your standard go-live timeline for a single-therapy program in Saudi Arabia?
• What are your data portability provisions in the event of contract termination?
• Describe your pilot program structure and the conditions under which a pilot converts to a full program.

---

Scoring and Pilot Terms

Scoring

Recommend assigning domain weights before receiving responses. Suggested starting weights aligned with Saudi PSP risk profile:

Each section is scored by the designated committee member(s), on a 1–5 scale, with written rationale for the score. Scores are aggregated before — not after — group discussion to avoid anchoring.

Pilot Terms

Define pilot conditions in the RFP itself:

• Duration: recommended 90–180 days for a Saudi single-therapy program
• Minimum enrollment to constitute a valid pilot: define by therapy volume expectations
• Success criteria: define specifically (AE capture rate, enrollment completion rate, patient retention, sponsor reporting accuracy) — not "the pilot performs well"
• Exit conditions: define what happens to patient data, coordinator relationships, and program infrastructure if the pilot does not convert to a full program

---

FAQ

What should a Saudi digital PSP RFP include that a standard SaaS RFP does not? Three elements are specific to Saudi PSP procurement: (1) pharmacovigilance infrastructure questions that require PV expertise to evaluate; (2) PDPL-specific privacy architecture questions; and (3) Arabic UX evaluation requirements that go beyond language localization to cover clinical workflow completeness in Arabic.

How long should the RFP process take for a Saudi PSP program? Recommended timeline: RFP issue to response receipt: 3–4 weeks. Evaluation and shortlisting: 2 weeks. Demo presentations from shortlisted vendors: 1 week. Reference checks: 1 week. Award and contract negotiation: 4–6 weeks. Total: approximately 12–16 weeks from RFP issue to contract signature. [VERIFY WITH BRAND — specific timelines subject to procurement policy]

What pilot terms should we include in the RFP? The RFP should specify the pilot duration, minimum enrollment threshold, defined success criteria with numerators and denominators, and the conditions under which the pilot converts to a full program agreement. Exit terms — what happens to patient data and infrastructure if the pilot does not convert — are equally important and must be pre-defined.

How many questions should a Saudi PSP RFP contain? A thorough RFP for a digital PSP platform in Saudi Arabia typically contains 80–120 questions across the six sections above. The question bank should be tiered: mandatory questions (non-response eliminates the vendor) and standard questions (scored). Avoid exceeding 150 questions — beyond that length, response quality typically declines.

How do we evaluate mandatory vs. scored questions? Mandatory questions are pass/fail thresholds. A vendor who cannot confirm in-Kingdom hosting availability (if that is required), or cannot provide a sample SDEA, or cannot demonstrate a live Arabic patient workflow, should be eliminated before scoring begins — regardless of how well they perform on other dimensions.

---

Published: 2026-11-05 · Author: CareSync Team · This article provides general information for procurement teams building RFP documentation for digital PSP programs in Saudi Arabia. It does not constitute legal, regulatory, or medical advice. All procurement processes should be reviewed with qualified advisors.

---

Ready to run your Saudi PSP RFP? Get the CareSync RFP question pack →